Evaluation of quality of life questionnaire regarding health
Functional Assessment of HIV infection in patients carriers of HIV
Abstract
Introduction: health related quality of life has become a measurement for effectiveness in the clinical studies of patients who a re HIV carriers, through the effectiveness of antretroviral treatments, even considering HIV as a chronic disease.
Objectives: to evaluate a tool for measuring the health related quality of life assessment (FAHI - Functional Assessment of HIV infection) and its association with a series of clinical, psychological and socio-demographical variables of a population living with HIV.
Methods: this is an analytical-descriptive study of the FAHI in patients carriers of HIV at the preventive medicine unit of the Uruguayan Medical Association Health Care Center (CASMU). We studied the validity and reliability of the instruments used.
Results: the FAHI proved to have adequate internal consistency. The presence of low CD4 lymphocyte count, greater viral load levels for HIV and/or AIDS staging according to the classification of the Centers for Disease Control and Prevention (CDC), were not associated with a worse perception of the FAHI. Receiving antiretroviral treatment was associated to a better functional level both in men and women, there being a worse perception of physical wellbeing among women.
Conclusion: the internal consistency of FAHI proved to be appropriate and it is a valid tool compared to the original one. We stand out the importance of evaluating the FAHI when it comes to deciding initiating or changing antiretroviral treatments. As to the psychological discomfort, SCL90-R was positively correlated with the perception of the health-related quality of life.
References
(2) Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, et al. Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002; 11(3): 273-82.
(3) Elliott AJ, Russo J, Roy-Byrne PP. The effect of changes in depression on health related quality of life (HRQoL) in HIV infection. Gen Hosp Psychiatry 2002; 24(1): 43-7.
(4) Douaihy A, Singh N. Factors affecting quality of life in patients with HIV infection. AIDS Read 2001; 11(9): 450-4, 460-1, 475.
(5) Burgoyne RW, Saunders DS. Quality of life among urban Canadian HIV/AIDS clinic outpatients. Int J Std AIDS 2001; 12(8): 505-12.
(6) Carvalho FT, Morais NA, Koller SH, Piccinini CA. Fatores de proteção relacionados à promoção de resiliência em pessoas que vivem com HIV/AIDS. Cad Saúde Pública 2007; 23(9): 2023-33.
(7) Schwartzmann L, Olaizola I, Guerra A, Dergazarian S, Francolino C, Porley G, et al. Validación de un instrumento para medir calidad de vida en hemodiálisis crónica: perfil de impacto de la enfermedad. Rev Med Urug 1999; 15(2): 103-9.
(8) Dapueto JJ, Francolino C, Servente L, Chang CH, Gotta I, Levin R, et al. Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish Version 4 in South America: classic psychometric and item response theory analyses. Health Qual Life Outcomes 2003; 1: 32.
(9) Beckman J, Ditlev G. Quality of life and empirical research. In: Aaronson NK, Beckman J, eds. The quality of life of cancer patients. New York: Raven Press, 1987: 37-40.
(10) Aaronson NK. Methodologic issues in assessing the quality of life of cancer patients. Cancer 1991; 67(3 Suppl): 844-50.
(11) Aaronson NK. Quantitative issues in health-related quality of life assessment. Health Policy 1988; 10(3): 217-30.
(12) Aaronson NK. Quality of life research in cancer clinical trials: a need for common rules and language. Oncology (Williston Park) 1990; 4(5): 59-66.
(13) Calman K. Definitions and dimensions of quality of life. In: Aaronson NK, Beckman J, eds. The quality of life of cancer patients. New York: Raven Press, 1987: 1-11.
(14) Schwartzmann L. Calidad de vida relacionada con la salud: aspectos conceptuales. Cienc Enferm 2003; 9(2): 9-21.
(15) Lenert LA, Feddersen M, Sturley A, Lee D. Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. Am J Med 2002; 113(3): 229-32.
(16) Cella DF. Manual for the functional assessment of cancer therapy (FACT) scales and functional assessment of HIV infection (FAHI) scale. 3rd ed. Chicago: Rush-Presbyterian-St. Luke’s Medical Center, 1994.
(17) Dapueto JJ, Francolino C, Gotta I, Levin R, Alonso I, Barrios E, et al. Evaluation of the Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G) in a South American Spanish speaking population. Psychooncology 2001; 10(1): 88-92.
(18) Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold, GL, Shnider B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960; 11(1): 7-33.
(19) Derogatis LR. SCL-90-R® Symptom Checklist-90-Revised Manual. NCS Pearson, 1975.
(20) Najson S, Luzardo M, Francolino C, Viera M. Uruguay. Universidad de la República. Comisión Sectorial de Investigación Científica. Programa CSIC: apoyo a investigadores. Montevideo: CSIC, 2007. [En prensa].
(21) Cella DF, McCain NL, Peterman AH, Mo F, Wolen D. Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 1996; 5(4): 450-63.
(22) Souza PR Borges de. Percepçao da qualidade de vida e do desempenho do sistema de saúde entre pacientes em terapia antirretroviral no Brasil. Thesis de la Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro: la Escola Nacional de Saúde Pública, 2009.
(23) Vinaccia S, Fernández H, Quinceno J, López M, Otalvaro C. Calidad de vida relacionada con la salud y apoyo social funcional en pacientes diagnosticados con VIH/Sida. Ter Psic 2008. 26(1): 125-32.
(24) Guimarães MD, Rocha GM, Campos LN, de Freitas FM, Gualberto FA, Teixeira RA, et al. Difficulties reported by HIV-infected patients using antiretroviral therapy in Brazil. Clinics (Sao Paulo) 2008; 63(2): 165-72.
(25) Starace F, Cafaro L, Abrescia N, Chirianni A, Izzo C, Rucci P, et al. Quality of life assessment in HIV-positive persons: application and validation of the WHOQOL-HIV, Italian version. AIDS Care 2002; 14(3): 405-15.
(26) García Ordónez MA, Mansilla Francisco JJ, Nieto Aragón E, Cereto MR, Salas Samper F, Vallejo Díaz J, et al. Calidad de vida relacionada con la salud de pacientes infectados por VIH medida por el cuestionario de Salud SF-36. An Med Interna 2001; 18(2): 74-9.
(27) Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ, Kass NE, et al. Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res 2000; 9(1): 55-63.
(28) Campsmith ML, Nakashima AK, Davidson AJ. Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project. Health Qual Life Outcomes 2003; 1: 12.
(29) Fernandes AP Morais, Sanches R Seron, Mill Y, Lucy D, Palha P Fredemir, Dalri MC Barcellos. Síndrome de la lipodistrofia asociado con la terapia antirretroviral en pacientes con VIH: consideraciones para los aspectos psicosociales. Rev Latinoam Enferm 2007; 15(5): 1041-5.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
